Veligrotug is a newly FDA-approved treatment that can target the proptosis associated with thyroid eye disease.
Michael Yen, MD
Advertisement
Oculosplastic surgeon at Baylor College of Medicine
Articles by Michael Yen, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
2
Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis
3
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain
4
AI Chatbots Score Below 28% on Colorectal Cancer Questions
5